hepatitis C
Telaprevir to be added to standard hep C therapy
March 27, 2011Research and Development, Sales and Marketing hepatitis C, telaprevir
Telaprevir – currently being co-developed by Vertex, Johnson & Johnson and Mitsubishi Tanabe – will become part of a standard …
J&J hepatitis C drug begins phase III trials
February 23, 2011Research and Development J&J, JJ, Johnson and Johnson, TMC435, Tibotec, hepatitis, hepatitis C
Johnson & Johnson has begun late stage trials of hepatitis C drug TMC435 as a first line treatment for the …
Regulators fast-track Merck’s hepatitis C drug boceprevir
January 7, 2011Sales and Marketing Merck & Co, boceprevir, hepatitis C, telaprevir
Merck’s new oral hepatitis C drug boceprevir will receive fast track reviews from both the FDA and the EMA after …
New hepatitis C drug offers cure for more patients
December 17, 2010Research and Development, Sales and Marketing HCV, Janssen, hepatitis C, liver disease, telaprevir
A new treatment from Janssen which could help cure many more patients with hepatitis C has been submitted in Europe. …
Abbott hep C drug ABT-450/r impresses in mid-stage trial
November 2, 2010Research and Development ABT-450/r, Abbott, Abbott Laboratories, American Liver Disease congress, Enanta Pharmaceuticals, Norvir, hepatitis C
Mid-stage trial results of Abbott Laboratories’ oral hepatitis C drug ABT-450/r have impressed at the American Liver Disease congress. The …
Latest content
FibroFind appoints Lee Borthwick as CEO
July 21, 2026
